Ewing Sarcoma as Secondary Malignant Neoplasm—Epidemiological and Clinical Analysis of an International Trial Registry

por Zöllner, Stefan K., Kauertz, Katja L., Kaiser, Isabelle, Kerkhoff, Maximilian, Schaefer, Christiane, Tassius, Madita, Jabar, Susanne, Jürgens, Heribert, Ladenstein, Ruth, Kühne, Thomas, Haveman, Lianne M., Paulussen, Michael, Ranft, Andreas, Dirksen, Uta
Publicado 2022

Relevance of Abnormal KCNN1 Expression and Osmotic Hypersensitivity in Ewing Sarcoma

por Fuest, Sebastian, Post, Christoph, Balbach, Sebastian T., Jabar, Susanne, Neumann, Ilka, Schimmelpfennig, Sandra, Sargin, Sarah, Nass, Elke, Budde, Thomas, Kailayangiri, Sareetha, Altvater, Bianca, Ranft, Andreas, Hartmann, Wolfgang, Dirksen, Uta, Rössig, Claudia, Schwab, Albrecht, Pethő, Zoltán
Publicado 2022

Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma

por Ohmura, Shunya, Marchetto, Aruna, Orth, Martin F., Li, Jing, Jabar, Susanne, Ranft, Andreas, Vinca, Endrit, Ceranski, Katharina, Carreño-Gonzalez, Martha J., Romero-Pérez, Laura, Wehweck, Fabienne S., Musa, Julian, Bestvater, Felix, Knott, Maximilian M. L., Hölting, Tilman L. B., Hartmann, Wolfgang, Dirksen, Uta, Kirchner, Thomas, Cidre-Aranaz, Florencia, Grünewald, Thomas G. P.
Publicado 2021

Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patients

por Sannino, Giuseppina, Marchetto, Aruna, Ranft, Andreas, Jabar, Susanne, Zacherl, Constanze, Alba-Rubio, Rebeca, Stein, Stefanie, Wehweck, Fabienne S., Kiran, Merve M., Hölting, Tilman L.B., Musa, Julian, Romero-Pérez, Laura, Cidre-Aranaz, Florencia, Knott, Maximilian M.L., Li, Jing, Jürgens, Heribert, Sastre, Ana, Alonso, Javier, Da Silveira, Willian, Hardiman, Gary, Gerke, Julia S., Orth, Martin F., Hartmann, Wolfgang, Kirchner, Thomas, Ohmura, Shunya, Dirksen, Uta, Grünewald, Thomas G.P.
Publicado 2019